| |
Nr 1 favoured product
|
Top 3 favoured products
|
|---|
|
Psychiatrist (n = 71)
|
Emergency physician (n = 37)
|
Fisher’s exact p
|
Psychiatrist (n = 71)
|
Emergency physician (n = 37)
|
Fisher’s exact p
|
|---|
|
Alprazolam LA
|
0 (0)
|
0 (0)
|
–
|
1 (1.4)
|
0 (0)
|
–
|
|
Alprazolam
|
1 (1.4)
|
1 (2.7)
|
1.000
|
4 (5.6)
|
3 (8.1)
|
0.689
|
|
Aripiprazole
|
3 (4.2)
|
0 (0)
|
0.55
|
7 (9.9)
|
0 (0)
|
0.093
|
|
Bromazepam
|
0 (0)
|
0 (0)
|
–
|
1 (1.4)
|
0 (0)
|
–
|
|
Clonazepam
|
0 (0)
|
0 (0)
|
–
|
0 (0)
|
1 (2.7)
|
–
|
|
Clorazepaat
|
2 (2.8)
|
2 (5.4)
|
0.605
|
9 (12.7)
|
7 (18.9)
|
0.404
|
|
Clotiapine
|
17 (23.9)
|
4 (10.8)
|
0.128
|
28 (39.4)
|
15 (40.5)
|
1.000
|
|
Diazepam
|
0 (0)
|
5 (13.5)
|
0.004
|
3 (4.2)
|
17 (45.9)
|
<0.001
|
|
Droperidol
|
5 (7.0)
|
2 (5.4)
|
1.000
|
17 (23.9)
|
11 (29.7)
|
0.644
|
|
Escitalopram
|
0 (0)
|
0 (0)
|
–
|
0 (0)
|
2 (5.4)
|
0.115
|
|
Haloperidol
|
3 (4.2)
|
4 (10.8)
|
0.228
|
6 (8.5)
|
14 (37.8)
|
<0.001
|
|
Lorazepam
|
14 (19.7)
|
9 (24.3)
|
0.625
|
43 (60.6)
|
15 (40.5)
|
0.067
|
|
Midazolam
|
0 (0)
|
2 (5.4)
|
0.115
|
0 (0)
|
6 (16.2)
|
0.001
|
|
Olanzapine
|
17 (23.9)
|
7 (18.9)
|
0.631
|
40 (56.3)
|
15 (40.5)
|
0.156
|
|
Paliperidone
|
0 (0)
|
0 (0)
|
–
|
1 (1.4)
|
0 (0)
|
–
|
|
Pipamperone
|
0 (0)
|
0 (0)
|
–
|
3 (4.2)
|
1 (2.7)
|
1.000
|
|
Prazepam
|
0 (0)
|
0 (0)
|
–
|
1 (1.4)
|
0 (0)
|
–
|
|
Promethiazine
|
0 (0)
|
0 (0)
|
–
|
0 (0)
|
1 (2.7)
|
–
|
|
Quetiapine
|
5 (7.0)
|
0 (0)
|
0.163
|
22 (31)
|
0 (0)
|
<0.001
|
|
Risperidone
|
2 (2.8)
|
0 (0)
|
0.545
|
6 (8.5)
|
1 (2.7)
|
0.418
|
|
Trazodone
|
0 (0)
|
0 (0)
|
–
|
1 (1.4)
|
0 (0)
|
–
|
|
Sodium Valproate
|
0 (0)
|
1 (2.7)
|
–
|
4 (5.6)
|
1 (2.7)
|
0.659
|
|
Zuclopenthixol
|
0 (0)
|
0 (0)
|
–
|
2 (2.8)
|
1 (2.7)
|
1.000
|
|
Zuclopenthixol LA
|
2 (2.8)
|
0 (0)
|
0.545
|
14 (19.7)
|
0 (0)
|
0.002
|
- Fisher’s exact test was performed when one of the two groups had at least two counts (two-sided).
